文献速递技术与安全腹部CT

双能CT碘摄取对免疫治疗黑色素瘤的预后价值

Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma.
PubMed 文献 · Eur J Radiol · 2026-08-05

回顾性分析73例接受免疫检查点抑制剂治疗的转移性黑色素瘤患者,共614个基线病灶,利用腹部双能CT测量病灶核心、过渡带及边缘区碘浓度并经门静脉归一化。结果显示基线边缘区碘浓度独立预测更短无进展生存期及更多新发病灶,但对单个基线病灶进展无显著预测价值。

要点

  • 基线病灶边缘区碘浓度越高,免疫治疗后无进展生存期越短
  • 边缘区碘浓度可预测前两次随访新发病灶负荷,但对单个基线病灶进展预测价值有限
  • 不同器官转移灶碘浓度与预后关系不一,淋巴结转移呈反向关联

核心结论

  • DECT基线病灶边缘区碘浓度独立预测免疫治疗转移性黑色素瘤更短无进展生存期及更多新发病灶负荷
  • 基线碘浓度与第二次随访时单个基线病灶进展无显著关联,提示其反映系统性而非病灶水平进展

研究设计与样本

  • 回顾性队列研究,纳入73例接受免疫检查点抑制剂治疗的转移性黑色素瘤患者,共614个基线病灶
  • 采用基线腹部双能CT检查,将每个病灶划分为三个同心壳层:核心、过渡带、边缘区
  • 碘浓度经门静脉摄取归一化得到mNIC,采用Cox比例风险回归校正病灶数量与肿瘤体积,Poisson回归分析新发转移

关键影像表现/征象

  • 基线mNIC与更短PFS的关联从核心向边缘区逐渐增强,边缘区mNIC经校正后仍独立相关
  • Kaplan-Meier分析证实边缘区mNIC可显著区分生存曲线
  • 脾、软组织、肝转移灶mNIC与预后呈显著正相关,淋巴结转移呈显著反向关联

诊断标准与关键数值

  • 边缘区mNIC经病灶数量与肿瘤体积校正后仍与更短PFS独立相关,过渡带呈临界显著性
  • 较高边缘区mNIC预测前两次随访期间更多新发病灶负荷

临床应用与阅片要点

  • 基线双能CT病灶边缘区碘浓度可作为转移性黑色素瘤免疫治疗前的无创预后指标
  • 阅片时应关注转移灶边缘区碘摄取而非仅整体测量,边缘高摄取提示系统性进展风险
  • 不同器官转移灶的碘摄取预后意义不同,淋巴结转移的关联方向相反,需按部位谨慎解读

局限性

  • 回顾性研究设计,样本量73例,单中心数据
  • 仅分析基线腹部双能CT,未涉及其他部位或治疗过程中影像变化

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Immune checkpoint inhibitors (ICI) have transformed melanoma treatment, but reliable prognostic biomarkers are lacking. Dual-energy CT (DECT)-derived iodine concentration is a non-invasive quantitative measure of tumor vascularity. We investigated whether spatially resolved baseline iodine concentration predicts ICI outcomes in metastatic melanoma.

METHODS: We retrospectively analyzed 73 patients with metastatic melanoma (614 baseline lesions) treated with ICI who underwent baseline abdominal DECT. Each lesion was partitioned into three concentric shells (core, transition zone, and rim) and iodine concentration was normalized to portal vein uptake (mNIC). Cox proportional hazards regression adjusting for lesion count and tumor volume was used to assess associations with progression-free survival (PFS). Poisson regression models were used to model new metastasis development.

RESULTS: Associations between baseline mNIC and shorter PFS increased from core to periphery. After adjustment, the peripheral rim remained independently associated with shorter PFS, while the transition zone showed borderline significance. Kaplan-Meier analysis confirmed significant survival separation for peripheral rim mNIC. Organ-specific analyses demonstrated heterogeneous effects, with splenic, soft tissue, and hepatic metastases showing significant positive associations, and lymph node metastases showing a significant inverse association. Higher peripheral mNIC also predicted greater new-lesion burden through the first two follow-up examinations. Baseline mNIC was not significantly associated with progressive disease of individual baseline lesions at second follow-up.

CONCLUSIONS: Peripheral tumor iodine concentration on dual-energy computed tomography independently predicts both shorter progression-free survival and greater new-lesion burden in immune checkpoint inhibitor-treated metastatic melanoma.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Bleymehl, Akbal, Schepers, et al. Baseline dual-energy CT iodine uptake predicts systemic but not lesion-level progression in immunotherapy-treated metastatic melanoma. Eur J Radiol. 2026. PMID: 42571761. doi:10.1016/j.ejrad.2026.113137

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。